Correction to Lancet Oncol 2025; 26: 367-77

No authors listed

Published Erratum

No authors listed. Lancet Oncol. 2025 Apr.

. 2025 Apr;26(4):e186.

doi: 10.1016/S1470-2045(25)00144-5.

No abstract available

Erratum for

Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61-20; Neo-N): a non-comparative, open-label, randomised, phase 2 trial.
Zdenkowski N, Kuper-Hommel MJJ, Niman SM, Francis PA, Baron-Hay S, Fox W, Menzies AM, Angus R, Punie K, Zardawi S, Regan MM, Loi S. Zdenkowski N, et al. Lancet Oncol. 2025 Mar;26(3):367-377. doi: 10.1016/S1470-2045(24)00757-5. Lancet Oncol. 2025. PMID: 40049198 Clinical Trial.